Clinical relevance of lymph node ratio in breast cancer patients with one to three positive lymph nodes

Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

(2011) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Lymph Node Ratio Should Be Considered for Incorporation into Staging for Breast Cancer

(2011) Anees B. Chagpar et al.   ANNALS OF SURGICAL ONCOLOGY

Prognostic Value of Number of Removed Lymph Nodes, Number of Involved Lymph Nodes, and Lymph Node Ratio in 7502 Breast Cancer Patients Enrolled onto Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG)

(2011) Christoph Tausch et al.   ANNALS OF SURGICAL ONCOLOGY

Comparison of Treatment Outcome Between Breast-Conservation Surgery With Radiation and Total Mastectomy Without Radiation in Patients With One to Three Positive Axillary Lymph Nodes

(2010) Seung Il Kim et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Improved Staging in Node-Positive Breast Cancer Patients Using Lymph Node Ratio: Results in 1,788 Patients with Long-term Follow-Up

(2010) Melissa E. Danko et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

(2009) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Lymph Node Ratio as an Alternative to pN Staging in Node-Positive Breast Cancer

(2009) Vincent Vinh-Hung et al.   JOURNAL OF CLINICAL ONCOLOGY

The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer

(2008) Pauline T Truong et al.   EUROPEAN JOURNAL OF CANCER

Elucidating the Role of Chest Wall Irradiation in ‘Intermediate-risk’ Breast Cancer: the MRC/EORTC SUPREMO Trial

(2007) I.H. Kunkler et al.   CLINICAL ONCOLOGY